Close Menu

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics announced today that it has received CE IVD marking for its next-generation sequencing-based HTG EdgeSeq system and its HTG EdgeSeq Diffuse Large B-Cell Lymphoma Cell of Origin Assay.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.